Vitamin d3 and Basal cell carcinoma - a phase IV clinical study of FDA data
We study 112,976 people who have side effects when taking Vitamin d3. Basal cell carcinoma is found, especially among people who are female, 60+ old, have been taking the drug for 5 - 10 years, also take Humira and have Rheumatoid arthritis.
The phase IV clinical study analyzes which people take Vitamin d3 and have Basal cell carcinoma. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
112,976 people reported to have side effects when taking Vitamin d3.
Among them, 359 people (0.32%) have Basal cell carcinoma.
What is Vitamin d3?
Vitamin d3 has active ingredients of ergocalciferol. It is used in mineral supplementation. Currently, eHealthMe is studying from 115,513 Vitamin d3 users.
What is Basal cell carcinoma?
Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills) is found to be associated with 1,920 drugs and 1,288 conditions by eHealthMe. Currently, we are studying 25,551 people who have Basal cell carcinoma.
Number of Vitamin d3 and Basal cell carcinoma reports submitted per year:
Time on Vitamin d3 when people have Basal cell carcinoma *:
Gender of people who have Basal cell carcinoma when taking Vitamin d3*:
Age of people who have Basal cell carcinoma when taking Vitamin d3 *:
Common drugs people take besides Vitamin d3 *:
Common side effects people have besides Basal cell carcinoma *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Vitamin d3 and have Basal cell carcinoma?Check whether Basal cell carcinoma is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
Vitamin d3 side effects by duration, gender and age:
- Vitamin d3 side effects (115,513 reports)
Basal cell carcinoma treatments and more:
- Basal cell carcinoma (25,551 reports)
Common drugs associated with Basal cell carcinoma:
- Methotrexate: 2,855 reports
- Humira: 2,500 reports
- Remicade: 2,468 reports
- Prednisone: 2,427 reports
- Enbrel: 1,845 reports
- Fosamax: 1,517 reports
- Aspirin: 1,395 reports
- Orencia: 1,171 reports
- Xeljanz: 1,040 reports
- Codeine: 1,027 reports
All the drugs that are associated with Basal cell carcinoma:
- Basal cell carcinoma (1,920 drugs)
Common conditions associated with Basal cell carcinoma:
- Rheumatoid arthritis: 3,325 reports
- Psoriasis: 1,732 reports
- Multiple sclerosis: 1,323 reports
- High blood pressure: 1,259 reports
- Crohn's disease: 1,072 reports
- Multiple myeloma: 988 reports
All the conditions that are associated with Basal cell carcinoma:
- Basal cell carcinoma (1,288 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ergocalciferol (the active ingredients of Vitamin d3) and Vitamin d3 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cabometyx and Pharyngitis - 4 seconds ago
- Tracleer and Bronchitis - 8 seconds ago
- Metformin Hydrochloride and Synjardy Xr drug interaction - 11 seconds ago
- Aldactazide and Procardia drug interaction - 11 seconds ago
- Estring and Dilaudid drug interaction - 21 seconds ago
- Tobi and Divalproex drug interaction - 25 seconds ago
- Avalide and Advair Diskus 100/50 drug interaction - 26 seconds ago
- Brintellix and Methotrexate drug interaction - 30 seconds ago
- Zemplar and Haematocrit Decreased - 32 seconds ago
- Atacand and Psoriatic Arthropathy - 33 seconds ago